Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMIXNASDAQ:GCTKNASDAQ:HSCSNASDAQ:NAYA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMIXAutonomix Medical$1.30-5.1%$1.78$1.24▼$42.40$3.61M-3.46335,175 shs173,932 shsGCTKGlucoTrack$0.09-10.4%$0.15$0.09▼$62.60$2.72M-0.192.58 million shs5.13 million shsHSCSHeart Test Laboratories$3.58-0.7%$3.51$2.36▼$5.77$3.87M2.56121,531 shs8,188 shsNAYANAYA Biosciences$1.46+2.8%$1.88$1.38▼$17.04$972K2.0353,151 shs67,585 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMIXAutonomix Medical-4.59%-0.72%-25.95%-25.95%-95.14%GCTKGlucoTrack-33.81%-22.93%-27.47%-70.99%-99.79%HSCSHeart Test Laboratories-2.96%+0.28%+8.11%+23.67%-32.08%NAYANAYA Biosciences+2.82%-8.18%-31.46%-42.80%+145,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMIXAutonomix Medical2.7053 of 5 stars3.52.00.00.02.51.71.3GCTKGlucoTrack1.3414 of 5 stars0.05.00.00.02.80.80.6HSCSHeart Test Laboratories2.6685 of 5 stars3.53.00.00.03.00.01.3NAYANAYA BiosciencesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMIXAutonomix Medical 3.00Buy$16.501,169.23% UpsideGCTKGlucoTrack 0.00N/AN/AN/AHSCSHeart Test Laboratories 3.00Buy$13.00263.64% UpsideNAYANAYA Biosciences 3.00Buy$24.001,543.84% UpsideCurrent Analyst Ratings BreakdownLatest NAYA, GCTK, HSCS, and AMIX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/29/2025AMIXAutonomix MedicalMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$5.003/18/2025HSCSHeart Test LaboratoriesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$15.00 ➝ $14.00(Data available from 6/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMIXAutonomix MedicalN/AN/AN/AN/A$8.12 per shareN/AGCTKGlucoTrackN/AN/AN/AN/A$15.30 per shareN/AHSCSHeart Test Laboratories$14.70K262.90N/AN/A$11.16 per share0.32NAYANAYA Biosciences$6.23M0.16N/AN/A($2.06) per share-0.71Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMIXAutonomix Medical-$15.43M-$7.47N/AN/AN/AN/A-212.48%-161.13%N/AGCTKGlucoTrack-$7.10M-$56.60N/A∞N/AN/A-826.43%-707.26%N/AHSCSHeart Test Laboratories-$6.61M-$7.48N/AN/AN/AN/A-117.76%-84.09%8/4/2025 (Estimated)NAYANAYA Biosciences-$8.03MN/A0.00∞N/A-119.91%N/A-41.72%6/29/2025 (Estimated)Latest NAYA, GCTK, HSCS, and AMIX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/29/2025Q4 2025AMIXAutonomix MedicalN/A-$0.74N/A-$0.74N/AN/A5/14/2025Q1 2025GCTKGlucoTrackN/A-$0.34N/A-$0.67N/AN/A3/13/2025Q3 2025HSCSHeart Test Laboratories-$2.53-$2.5722-$0.0422-$2.57N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMIXAutonomix MedicalN/AN/AN/AN/AN/AGCTKGlucoTrackN/AN/AN/AN/AN/AHSCSHeart Test LaboratoriesN/AN/AN/AN/AN/ANAYANAYA BiosciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMIXAutonomix MedicalN/A5.315.31GCTKGlucoTrackN/A0.140.14HSCSHeart Test Laboratories0.011.721.52NAYANAYA BiosciencesN/A0.230.20Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMIXAutonomix Medical10.78%GCTKGlucoTrack10.92%HSCSHeart Test Laboratories17.24%NAYANAYA Biosciences12.02%Insider OwnershipCompanyInsider OwnershipAMIXAutonomix Medical32.40%GCTKGlucoTrack12.91%HSCSHeart Test Laboratories1.80%NAYANAYA Biosciences1.79%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMIXAutonomix Medical12.78 million1.67 millionN/AGCTKGlucoTrack528.64 million5.57 millionNot OptionableHSCSHeart Test Laboratories101.08 million962,000Not OptionableNAYANAYA Biosciences10666,0004.40 millionN/ANAYA, GCTK, HSCS, and AMIX HeadlinesRecent News About These CompaniesINVO Fertility, Inc.: INVO Fertility Confirms New Nasdaq Trading Symbol of "IVF"April 29, 2025 | finanznachrichten.deINVO Fertility Inc.April 29, 2025 | barrons.comINVO Fertility announces new Nasdaq trading symbolApril 25, 2025 | markets.businessinsider.comMaxim Group downgrades NAYA Biosciences (NAYA) to a HoldApril 25, 2025 | markets.businessinsider.comINVO Fertility Confirms New Nasdaq Trading Symbol of “IVF”April 24, 2025 | globenewswire.comNAYA Biosciences IncApril 18, 2025 | morningstar.comNAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”April 14, 2025 | globenewswire.comNAYA BIOSCIENCES Earnings Preview: Recent $NAYA Insider Trading, Hedge Fund Activity, and MoreApril 14, 2025 | nasdaq.comNAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025March 13, 2025 | globenewswire.comNAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility TreatmentFebruary 25, 2025 | globenewswire.comNAYA Biosciences Announces Nomination of New Board MembersFebruary 19, 2025 | globenewswire.comNAYA Stock Hits 52-Week Low at $0.35 Amid Market ChallengesFebruary 12, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNAYA, GCTK, HSCS, and AMIX Company DescriptionsAutonomix Medical NASDAQ:AMIX$1.30 -0.07 (-5.11%) Closing price 03:57 PM EasternExtended Trading$1.30 0.00 (0.00%) As of 04:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.GlucoTrack NASDAQ:GCTK$0.09 -0.01 (-10.39%) Closing price 04:00 PM EasternExtended Trading$0.09 0.00 (-2.32%) As of 04:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.Heart Test Laboratories NASDAQ:HSCS$3.58 -0.03 (-0.69%) Closing price 03:58 PM EasternExtended Trading$3.55 -0.03 (-0.70%) As of 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.NAYA Biosciences NASDAQ:NAYA$1.46 +0.04 (+2.82%) As of 06/11/2025NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Fastenal Stock After Split: Poised for 5 More Years of Gains Analysts Love Lovesac, But Investors Should Be Cautious Oracle’s Cloud Boom Is Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
